Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in the Middle East Training Course" has been added to ResearchAndMarkets.com's offering.
This seminar will provide you with an essential overview of the key areas of pharmaceutical regulatory affairs in the Middle East. This two-day course will focus on practical aspects and will cover the regulatory requirements and developments in the individual countries as well as discuss harmonisation in the region.
Benefits of attending:
- Gain an overview of the regulatory environment in the Middle East
- Understand the economic and cultural background to the markets
- Clarify procedures for company and product registration
- Discuss harmonisation and recent developments in the region
Certification:
- CPD: 12 hours for your records
- Certificate of completion
Who Should Attend:
- Personnel involved in pharmaceutical regulatory affairs in the Middle East
- Anyone new to the region
- All those interested in an update on recent developments
Key Topics Covered:
Introduction to Regulatory Affairs in the Middle East
General overview on the following topics:
- Markets and Culture
- Healthcare
- Business culture
- Regulatory environment and characteristics
- General regulatory requirements
- Company and product registration
- Variations and renewals
- Pharmacovigilance
- Regulatory summary
Economic Overview of the Middle East
- Population and GDP per capita
- Unemployment rate
- GDP real growth rate
- Inflation rate
- Healthcare spend per capita
The pharmaceutical regulatory environment in the Middle East - with individual presentations on:
- Bahrain
- Egypt
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Libya
- Oman
- Palestine
- Qatar
- Saudi Arabia
- Sudan
- Syria
- UAE
- Yemen
Harmonisation and recent developments
- Centralised registration in the Gulf
- Gulf Central Committee for Drug Registration (GCC-DR)
- SGH Tender
- Middle East Regulatory Conference (MERC)
- MERC follow-up activities
- Industry regulatory groups and activities
- Local trade associations
Final discussion and objectives review
Speakers:
Heba Hashem
Middle East and Africa Associate Director
PPD
Heba has been working with Regulatory Affairs in the Middle East for more than 25 years. She has a Pharmaceutical and Business background being a graduate of the Faculty of Pharmacy (Cairo University), RAC certified in addition to an MBA at Maastricht School of Business. For the past 20 years Heba held the position of Middle East & Africa Regulatory and Quality Head at different Pharmaceutical and Medical Device companies; Gambro, Bayer and Novo Nordisk.
Heba is now the Middle East and Africa Associate Director at PPD where she is providing regulatory consulting services and training to Health Care companies.
Ilona Putz
Founder
PULONA
Ilona Putz founded PULONA Emerging Markets based in the UAE which is dedicated to creating and developing tailor-made business concepts for clients in the healthcare sector across the Middle East.
She has worked in the pharmaceutical industry since 1988 for companies like MSD, SmithKline Beecham, Karl Engelhard and HEXAL where she has held the position of Regulatory Affairs Regional Manager, responsible for regulatory affairs and later on in commercial operations for countries in the Middle East and Africa. Between 2005 and August 2008 she was Regional Head, Middle East, for Sandoz International, Germany, responsible for all commercial and business development activities.
For more information about this conference visit https://www.researchandmarkets.com/r/ki6unc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
